Imaglif
Brand Name: Imaglif
Generic Name: Empagliflozin
Active
Registration Number
DRP-16372
Dosage Form
Film Coated Tablet
Issuance Date
February 20, 2025
Expiry Date
February 20, 2030
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength25 mg
PackagingAlu/PVC Blister Pack x 10's (Box of 30's)
Classification
C
Classification
Prescription (Rx) Drug
P
Pharmacologic
Sodium-glucose co-transporter 2 (SGLT2) inhibitor
A
Application
Initial
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
EmpagliflozinActive
Monograph: Empagliflozin